Home » Nebraska Raises Stakes in Battle With FDA, Won’t Surrender Supply of Controversial Drug
Nebraska Raises Stakes in Battle With FDA, Won’t Surrender Supply of Controversial Drug
The state of Nebraska, engaged in an ongoing battle with the FDA over its supply of a controversial anesthetic drug used in executions, confirmed it will defy an FDA order to hand over remaining supplies of sodium thiopental.
Regulatory Focus
Regulatory Focus
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May